LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about the broad US market.
Directly affected
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF+0.6% 12d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that AbbVie belongs to, so it often moves with news about it.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+5.2% 30d
Pfizer is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- VRTX Vertex Pharmaceuticals+3.0% 30d
Vertex Pharmaceuticals is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LLY | -7.22% | -6.69% | base | +3.17% | +2.79% | +2.62% | +3.25% |
| ABBV | -1.73% | -1.50% | base | +1.40% | -0.66% | -1.67% | +0.95% |
| DIA | -0.27% | +0.09% | base | -1.10% | -0.66% | -1.10% | +1.97% |
| QQQ | -1.57% | +0.81% | base | -3.48% | -4.74% | -4.21% | -3.32% |
| XLV | -2.61% | -2.65% | base | +0.46% | +0.32% | -0.02% | +3.05% |
| JNJ | -4.11% | -2.34% | base | -0.69% | -1.67% | -3.27% | +0.43% |
| MRK | -0.71% | -3.06% | base | +2.20% | +1.45% | -1.13% | +2.76% |
| ABT | -0.84% | -1.37% | base | +1.61% | +5.48% | +4.63% | +10.83% |
| PFE | +0.20% | -0.53% | base | +1.84% | +2.54% | +0.10% | +2.80% |
| VRTX | -3.00% | -3.53% | base | +3.50% | +2.49% | -1.69% | +1.67% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +1.40% | final price |
| ABBV | the next day | -0.66% | final price |
| ABBV | two days later | -1.67% | final price |
| ABBV | three days later | +0.95% | final price |
| ABBV | three days earlier | -1.50% | final price |
| ABBV | five days earlier | -1.73% | final price |
| ABT | that day | +1.61% | final price |
| ABT | the next day | +5.48% | final price |
| ABT | two days later | +4.63% | final price |
| ABT | three days later | +10.83% | final price |
| ABT | three days earlier | -1.37% | final price |
| ABT | five days earlier | -0.84% | final price |
| DIA | that day | -1.10% | final price |
| DIA | the next day | -0.66% | final price |
| DIA | two days later | -1.10% | final price |
| DIA | three days later | +1.97% | final price |
| DIA | three days earlier | +0.09% | final price |
| DIA | five days earlier | -0.27% | final price |
| JNJ | that day | -0.69% | final price |
| JNJ | the next day | -1.67% | final price |
| JNJ | two days later | -3.27% | final price |
| JNJ | three days later | +0.43% | final price |
| JNJ | three days earlier | -2.34% | final price |
| JNJ | five days earlier | -4.11% | final price |
| LLY | that day | +3.17% | final price |
| LLY | the next day | +2.79% | final price |
| LLY | two days later | +2.62% | final price |
| LLY | three days later | +3.25% | final price |
| LLY | three days earlier | -6.69% | final price |
| LLY | five days earlier | -7.22% | final price |
| MRK | that day | +2.20% | final price |
| MRK | the next day | +1.45% | final price |
| MRK | two days later | -1.13% | final price |
| MRK | three days later | +2.76% | final price |
| MRK | three days earlier | -3.06% | final price |
| MRK | five days earlier | -0.71% | final price |
| PFE | that day | +1.84% | final price |
| PFE | the next day | +2.54% | final price |
| PFE | two days later | +0.10% | final price |
| PFE | three days later | +2.80% | final price |
| PFE | three days earlier | -0.53% | final price |
| PFE | five days earlier | +0.20% | final price |
| QQQ | that day | -3.48% | final price |
| QQQ | the next day | -4.74% | final price |
| QQQ | two days later | -4.21% | final price |
| QQQ | three days later | -3.32% | final price |
| QQQ | three days earlier | +0.81% | final price |
| QQQ | five days earlier | -1.57% | final price |
| VRTX | that day | +3.50% | final price |
| VRTX | the next day | +2.49% | final price |
| VRTX | two days later | -1.69% | final price |
| VRTX | three days later | +1.67% | final price |
| VRTX | three days earlier | -3.53% | final price |
| VRTX | five days earlier | -3.00% | final price |
| XLV | that day | +0.46% | final price |
| XLV | the next day | +0.32% | final price |
| XLV | two days later | -0.02% | final price |
| XLV | three days later | +3.05% | final price |
| XLV | three days earlier | -2.65% | final price |
| XLV | five days earlier | -2.61% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 4 days after publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 10 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 23 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 46 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 23 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 30 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 72 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 23 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today” scores 12 out of 100. The score uses 1 sources.